TATE vs. GLB, CWK, PFD, BAKK, GNC, DCG, HFG, BD15, ZAM, and PURE
Should you be buying Tate & Lyle stock or one of its competitors? The main competitors of Tate & Lyle include Glanbia (GLB), Cranswick (CWK), Premier Foods (PFD), Bakkavor Group (BAKK), Greencore Group (GNC), Dairy Crest Group (DCG), Hilton Food Group (HFG), Tate & Lyle (BD15), Zambeef Products (ZAM), and PureCircle (PURE). These companies are all part of the "packaged foods" industry.
Tate & Lyle vs. Its Competitors
Tate & Lyle (LON:TATE) and Glanbia (LON:GLB) are both mid-cap consumer defensive companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends.
Tate & Lyle has a net margin of 11.41% compared to Glanbia's net margin of 7.89%. Tate & Lyle's return on equity of 15.37% beat Glanbia's return on equity.
Tate & Lyle currently has a consensus price target of GBX 676.67, indicating a potential upside of 28.28%. Given Tate & Lyle's stronger consensus rating and higher probable upside, analysts plainly believe Tate & Lyle is more favorable than Glanbia.
76.4% of Tate & Lyle shares are held by institutional investors. Comparatively, 26.8% of Glanbia shares are held by institutional investors. 2.2% of Tate & Lyle shares are held by insiders. Comparatively, 30.6% of Glanbia shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Glanbia has higher revenue and earnings than Tate & Lyle. Tate & Lyle is trading at a lower price-to-earnings ratio than Glanbia, indicating that it is currently the more affordable of the two stocks.
In the previous week, Glanbia had 1 more articles in the media than Tate & Lyle. MarketBeat recorded 2 mentions for Glanbia and 1 mentions for Tate & Lyle. Tate & Lyle's average media sentiment score of 0.67 beat Glanbia's score of 0.25 indicating that Tate & Lyle is being referred to more favorably in the media.
Tate & Lyle pays an annual dividend of GBX 19 per share and has a dividend yield of 3.6%. Glanbia pays an annual dividend of GBX 37 per share and has a dividend yield of 259.8%. Tate & Lyle pays out 39.6% of its earnings in the form of a dividend. Glanbia pays out 7,340.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
Tate & Lyle has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500. Comparatively, Glanbia has a beta of 0.47, suggesting that its stock price is 53% less volatile than the S&P 500.
Summary
Tate & Lyle beats Glanbia on 11 of the 18 factors compared between the two stocks.
Get Tate & Lyle News Delivered to You Automatically
Sign up to receive the latest news and ratings for TATE and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding TATE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Tate & Lyle Competitors List
Related Companies and Tools
This page (LON:TATE) was last updated on 8/16/2025 by MarketBeat.com Staff